Robert E. Landry - Dec 8, 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Signature
/s/**Robert E. Landry
Stock symbol
REGN
Transactions as of
Dec 8, 2021
Transactions value $
-$1,101,437
Form type
4
Date filed
12/10/2021, 04:37 PM
Previous filing
Nov 18, 2021
Next filing
Dec 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Award $0 +3.97K +15.28% $0.00 30K Dec 8, 2021 Direct F1
transaction REGN Common Stock Options Exercise $1.7M +4.25K +14.19% $399.66 34.2K Dec 9, 2021 Direct F2
transaction REGN Common Stock Tax liability -$2.28M -3.47K -10.14% $657.11 30.7K Dec 9, 2021 Direct F2
transaction REGN Common Stock Sale -$1.31K -2 -0.01% $656.46 30.7K Dec 10, 2021 Direct F2
transaction REGN Common Stock Sale -$32.9K -50 -0.16% $657.53 30.7K Dec 10, 2021 Direct F2, F3
transaction REGN Common Stock Sale -$7.24K -11 -0.04% $658.52 30.7K Dec 10, 2021 Direct F2, F4
transaction REGN Common Stock Sale -$2.64K -4 -0.01% $659.49 30.7K Dec 10, 2021 Direct F2, F5
transaction REGN Common Stock Sale -$16.5K -25 -0.08% $661.48 30.6K Dec 10, 2021 Direct F2, F6
transaction REGN Common Stock Sale -$81.4K -123 -0.4% $662.06 30.5K Dec 10, 2021 Direct F2, F7
transaction REGN Common Stock Sale -$12.6K -19 -0.06% $663.41 30.5K Dec 10, 2021 Direct F2, F8
transaction REGN Common Stock Sale -$9.97K -15 -0.05% $664.71 30.5K Dec 10, 2021 Direct F2
transaction REGN Common Stock Sale -$12K -18 -0.06% $665.44 30.5K Dec 10, 2021 Direct F2, F9
transaction REGN Common Stock Sale -$45.3K -68 -0.22% $666.19 30.4K Dec 10, 2021 Direct F2
transaction REGN Common Stock Sale -$4.67K -7 -0.02% $667.80 30.4K Dec 10, 2021 Direct F2, F10
transaction REGN Common Stock Sale -$119K -178 -0.59% $668.21 30.2K Dec 10, 2021 Direct F2, F11
transaction REGN Common Stock Sale -$87K -130 -0.43% $669.48 30.1K Dec 10, 2021 Direct F2, F12
transaction REGN Common Stock Sale -$38.9K -58 -0.19% $670.13 30K Dec 10, 2021 Direct F2, F13
transaction REGN Common Stock Sale -$9.4K -14 -0.05% $671.42 30K Dec 10, 2021 Direct F2, F14
transaction REGN Common Stock Sale -$39.7K -59 -0.2% $672.30 30K Dec 10, 2021 Direct F2
holding REGN Common Stock 229 Dec 8, 2021 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -4.25K -20% $0.00 17K Dec 9, 2021 Common Stock 4.25K $399.66 Direct F2, F15
transaction REGN Non-Qualified Stock Option (right to buy) Award $0 +17K $0.00 17K Dec 8, 2021 Common Stock 17K $644.54 Direct F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 8, 2023 and 50% on December 8, 2025.
F2 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F3 Represents volume-weighted average price of sales of 50 shares of Company stock on December 10, 2021 at prices ranging from $657.19 to $657.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F4 Represents volume-weighted average price of sales of 11 shares of Company stock on December 10, 2021 at prices ranging from $658.10 to $658.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F5 Represents volume-weighted average price of sales of 4 shares of Company stock on December 10, 2021 at prices ranging from $659.36 to $659.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F6 Represents volume-weighted average price of sales of 25 shares of Company stock on December 10, 2021 at prices ranging from $661.26 to $661.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F7 Represents volume-weighted average price of sales of 123 shares of Company stock on December 10, 2021 at prices ranging from $662.06 to $662.17. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F8 Represents volume-weighted average price of sales of 19 shares of Company stock on December 10, 2021 at prices ranging from $663.16 to $663.53. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F9 Represents volume-weighted average price of sales of 18 shares of Company stock on December 10, 2021 at prices ranging from $665.20 to $665.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F10 Represents volume-weighted average price of sales of 7 shares of Company stock on December 10, 2021 at prices ranging from $667.39 to $667.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F11 Represents volume-weighted average price of sales of 178 shares of Company stock on December 10, 2021 at prices ranging from $668.10 to $668.50. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F12 Represents volume-weighted average price of sales of 130 shares of Company stock on December 10, 2021 at prices ranging from $669.43 to $669.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F13 Represents volume-weighted average price of sales of 58 shares of Company stock on December 10, 2021 at prices ranging from $670.12 to $670.62. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F14 Represents volume-weighted average price of sales of 14 shares of Company stock on December 10, 2021 at prices ranging from $671.42 to $671.43. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on December 10, 2021 at each separate price.
F15 The stock option award vests in four equal annual installments, commencing one year after the date of grant.